<table id="i72895749-5603-494f-8bf2-1bc41e7f168f" width="100%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>Effects on Steady-State Fexofenadine Pharmacokinetics After 7 Days of 
Co-Administration with Fexofenadine Hydrochloride 120 mg Every 12 Hours (two 
times the recommended twice daily dose) in Healthy Volunteers (n=24)</caption>
<col align="center" width="30%"></col>
<col align="center" width="35%"></col>
<col align="center" width="35%"></col>
<thead>
<tr>
<th>
<content stylecode="italics">Concomitant Drug</content>
</th>
<th>
<content stylecode="italics">C<sub>max 
SS</sub>
<br/>(Peak plasma concentration)</content>
</th>
<th>
<content stylecode="italics">AUC<sub>SS</sub>(0â€“12h)<br/>(Extent of systemic 
exposure)</content>
</th>
</tr>
</thead>
<tbody>
<tr>
<td>Erythromycin<br/>(500 mg every 8 hrs)</td>
<td>+82%</td>
<td>+109%</td>
</tr>
<tr>
<td>Ketoconazole<br/>(400 mg once daily)</td>
<td>+135%</td>
<td>+164%</td>
</tr>
</tbody>
</table>